Literature DB >> 20000655

Neurotrophic effects of tianeptine on hippocampal neurons: a proteomic approach.

Chin-Chen Chu1, Jhi-Joung Wang, Kuan-Ting Chen, Ja-Ping Shieh, Li-Kai Wang, Hao-Ai Shui, Shung-Tai Ho.   

Abstract

Tianeptine, an atypical tricyclic antidepressant with unique characteristics, can improve memory and prevent stress-induced hippocampal damage. It has neuroplastic and neurotrophic effects on hippocampal neurons and can prevent dendritic atrophy of the hippocampus in certain pathological conditions. To obtain a better understanding of the underlying mechanisms, we performed a proteomic analysis on tianeptine-treated hippocampal neurons. Primary hippocampal neurons were prepared from fetal Sprague-Dawley rats, eliminating glia cells by addition of cytosine beta-D-arabinofuranoside at day 2 in vitro (DIV2). The neurons were treated with tianeptine (10 microg/mL) or vehicle at DIV3, then harvested at DIV4 or DIV9 for immunocytochemical analysis of, respectively, neurite outgrowth or synapse formation. A proteomics analysis was performed on DIV4 neurons and the data were confirmed by Western blot analysis. Using specific markers, we demonstrated that tianeptine can augment neurite growth and promote synaptic contacts in cultured hippocampal neurons. The proteomics analysis identified 11 differentially expressed proteins, with roles in neurite growth, metabolism of neurotrophic substances, synaptogenesis, and synaptic activity homeostasis. The data shed light on the mechanisms underlying the neurotrophic effect of tianeptine observed in both animal studies and the clinic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20000655     DOI: 10.1021/pr900799b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  6 in total

Review 1.  Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.

Authors:  Kenneth Hensley; Kalina Venkova; Alexandar Christov; William Gunning; Joshua Park
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

2.  Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function.

Authors:  Aaron M Swomley; Judy C Triplett; Jeriel T Keeney; Govind Warrier; Kevin J Pearson; Julie A Mattison; Rafael de Cabo; Jian Cai; Jon B Klein; D Allan Butterfield
Journal:  J Nutr Biochem       Date:  2016-10-13       Impact factor: 6.048

3.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01

Review 4.  Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.

Authors:  Kenneth Hensley; Petri Kursula
Journal:  J Alzheimers Dis       Date:  2016-04-15       Impact factor: 4.472

5.  Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model.

Authors:  Hwayoung Lee; Jiyun Im; Hansol Won; Wooyoung Nam; Young Ock Kim; Sang Won Lee; Sanghyun Lee; Ik-Hyun Cho; Hyung-Ki Kim; Jun-Tack Kwon; Hak-Jae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-06-26       Impact factor: 2.016

6.  The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways.

Authors:  D Jantas; S Krawczyk; W Lason
Journal:  Neurotox Res       Date:  2013-10-09       Impact factor: 3.911

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.